Distigmine Bromide, formerly known as Ubretid and BC-51, is an acetylcholinesterase inhibitor used for the treatment of underactive neurogenic bladder and myasthenia gravis. References: Kobayashi K, Sekiguchi H, Sato N, Hirose Y. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment]. Chudoku Kenkyu. 2016 Mar;29(1):26-9. Japanese. PubMed PMID: 27255021.

纯度：≥98%

CAS：15876-67-2